Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers > Retina Specialists

Dr. Charles Clifton Wykoff, PHD, MD

(No ratings)

Specializes in: Vitreoretinal Diseases (Retina and Vitreous)

Harvard Medical School (2005)

Professional interests include: retinitis pigmentosa, diabetic retinopathy, vitreous problems, and more.

400 Bypass Lane Suite 105
Livingston, TX 77351

(713) 524-3434

Dr. Charles Clifton Wykoff, PHD, MD is a retina specialist in Houston, TX specializing in vitreoretinal diseases (retina and vitreous). He graduated from Harvard Medical School in 2005 and has 19 years of experience. Dr. Charles Clifton Wykoff, PHD, MD is affiliated with Baylor College of Medicine, Houston Methodist, Memorial Hermann and RETINA CONSULTANTS OF HOUSTON PLLC.

Office Locations

Address:

10100 Katy Freeway Suite 100
Houston, TX 77043

Address:

10119 Us 59 Highway Suite 4
Wharton, TX 77488

Address:

10907 Memorial Hermann Drive Suite 405
Pearland, TX 77584

Address:

11460 Space Center Boulevard Suite 2
Houston, TX 77059

Address:

16605 Southwest Freeway Suite 305
Sugar Land, TX 77479

Address:

17450 St. Lukes Way Suite 400
The Woodlands, TX 77384

Address:

21216 Northwest Freeway Suite 520
Cypress, TX 77429

Address:

23501 Cinco Ranch Boulevard Suite G205
Katy, TX 77494

Address:

23510 Kingsland Boulevard Suite 300
Katy, TX 77494

Address:

2620 Becker Drive
Brenham, TX 77833

Address:

2906 Brentwood Drive Suite 300
Lufkin, TX 75901

Address:

350 Kingwood Medical Drive Suite 200
Kingwood, TX 77339

Address:

400 Bypass Lane Suite 105
Livingston, TX 77351

Address:

4460 Bissonnet Street Suite 200
Bellaire, TX 77401

Address:

5300 North Street
Nacogdoches, TX 75965

Address:

6750 West Loop S Suite 1060
Bellaire, TX 77401

Address:

800 Peakwood Drive Suite 1c
Houston, TX 77090

Address:

9600 Bellaire Boulevard Suite 211
Houston, TX 77036

In The News (see more mentions in the news)

“"There remains a tremendous need for new therapies with differentiated mechanisms of action to treat dry AMD, especially those that could be readily employed for the management of earlier stages of...”—"Stealth BioTherapeutics Announces First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration", KTLA 5, June 2024

“"There remains a tremendous unmet need for safe and effective oral therapeutics that can slow the progression of NPDR and PDR and improve diabetic retinopathy severity levels," said Charles...”—"Valo Health Completes Enrollment of OPL-0401 Phase 2 Study for the Treatment of Diabetic Retinopathy", News10, March 2024

“Dr. Charles C. Wykoff, M.D., PhD, a board-certified Medical and Surgical Retina Specialist, Director of Research at Retina Consultants of Texas(tm), and Chief Investigator of the Phase 3 COAST...”—"Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept", Fox31 Denver, February 2024

diagnostic imaging	11
doctor visit	183
eye procedures	3958
injections	1321
photocoagulation	19
ultrasound (sonogram)	11

**Gender**
Male	330
Female	436

**Ethnicity**
Non-Hispanic White	651
Black	35
Hispanic	52
Asian	16
Other	0
Native American	0

**Age**
From 65 to 74	284
From 75 to 84	250
85 and over	174
Less than 65	58

Hypertension	75
High Cholesterol	61
Stroke	7
Ischemic Heart Disease	45
Depression	16
Chronic Kidney Disease	23
Asthma	4
Osteoperosis	10
Atrial Fibrilation	13
Heart Failure	24
Chronic Obstructive Pulmonary Disease	15
Diabetes	39
Dementia	12
Cancer	9

aspiration	18
doctor visit	177
eye procedures	4437
injections	1353
photocoagulation	64
prophylaxis (preventive treatment)	12

**Gender**
Male	339
Female	428

**Ethnicity**
Non-Hispanic White	632
Black	46
Hispanic	56
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	314
From 75 to 84	239
85 and over	167
Less than 65	47

Hypertension	75
High Cholesterol	59
Stroke	7
Ischemic Heart Disease	39
Depression	20
Chronic Kidney Disease	24
Asthma	6
Osteoperosis	9
Atrial Fibrilation	14
Heart Failure	23
Chronic Obstructive Pulmonary Disease	14
Diabetes	39
Dementia	11
Cancer	10

aspiration	30
diagnostic imaging	16
doctor visit	201
eye procedures	5558
injections	1774
photocoagulation	72
prophylaxis (preventive treatment)	18
ultrasound (sonogram)	16

**Gender**
Male	896
Female	1028

**Ethnicity**
Non-Hispanic White	1608
Black	106
Hispanic	136
Asian	46
Other	0
Native American	0

**Age**
From 65 to 74	766
From 75 to 84	640
85 and over	398
Less than 65	120

Hypertension	75
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	40
Depression	13
Chronic Kidney Disease	27
Asthma	10
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	24
Chronic Obstructive Pulmonary Disease	15
Diabetes	38
Dementia	9
Cancer	11

diagnostic imaging	16
doctor visit	217
eye procedures	6005
injections	1879
photocoagulation	63
prophylaxis (preventive treatment)	16
ultrasound (sonogram)	16

**Gender**
Male	462
Female	539

**Ethnicity**
Non-Hispanic White	851
Black	45
Hispanic	68
Asian	23
Other	0
Native American	0

**Age**
From 65 to 74	386
From 75 to 84	344
85 and over	217
Less than 65	54

Hypertension	75
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	38
Depression	15
Chronic Kidney Disease	33
Asthma	13
Osteoperosis	8
Atrial Fibrilation	12
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	39
Dementia	12
Cancer	11

diagnostic imaging	13
doctor visit	215
eye procedures	6918
injections	2210
photocoagulation	69
prophylaxis (preventive treatment)	35
ultrasound (sonogram)	13

**Gender**
Male	446
Female	598

**Ethnicity**
Non-Hispanic White	899
Black	42
Hispanic	58
Asian	0
Other	23
Native American	0

**Age**
From 65 to 74	434
From 75 to 84	342
85 and over	220
Less than 65	48

Hypertension	75
High Cholesterol	52
Stroke	6
Ischemic Heart Disease	39
Depression	18
Chronic Kidney Disease	32
Asthma	5
Osteoperosis	10
Atrial Fibrilation	14
Heart Failure	20
Chronic Obstructive Pulmonary Disease	14
Diabetes	37
Dementia	13
Cancer	11

doctor visit	216
eye procedures	6882
injections	2120
photocoagulation	57
prophylaxis (preventive treatment)	30

**Gender**
Male	454
Female	606

**Ethnicity**
Non-Hispanic White	882
Black	45
Hispanic	66
Asian	0
Other	33
Native American	0

**Age**
From 65 to 74	453
From 75 to 84	356
85 and over	194
Less than 65	57

Hypertension	75
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	38
Depression	16
Chronic Kidney Disease	33
Asthma	6
Osteoperosis	11
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	13
Diabetes	36
Dementia	11
Cancer	11

doctor visit	194
eye procedures	7727
injections	2432
photocoagulation	37
prophylaxis (preventive treatment)	22

**Gender**
Male	518
Female	653

**Ethnicity**
Non-Hispanic White	974
Black	52
Hispanic	67
Asian	43
Other	0
Native American	0

**Age**
From 65 to 74	519
From 75 to 84	384
85 and over	214
Less than 65	54

Hypertension	75
High Cholesterol	65
Stroke	6
Ischemic Heart Disease	38
Depression	16
Chronic Kidney Disease	34
Asthma	6
Osteoperosis	11
Atrial Fibrilation	13
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	34
Dementia	13
Cancer	13

doctor visit	201
eye procedures	7729
injections	2677
photocoagulation	10
prophylaxis (preventive treatment)	12

**Gender**
Male	473
Female	631

**Ethnicity**
Non-Hispanic White	934
Black	39
Hispanic	66
Asian	38
Other	0
Native American	0

**Age**
From 65 to 74	473
From 75 to 84	371
85 and over	194
Less than 65	66

Hypertension	75
High Cholesterol	62
Stroke	5
Ischemic Heart Disease	37
Depression	17
Chronic Kidney Disease	35
Asthma	6
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	17
Chronic Obstructive Pulmonary Disease	9
Diabetes	35
Dementia	11
Cancer	10

doctor visit	335
eye procedures	16420
injections	5226
photocoagulation	40
prophylaxis (preventive treatment)	42

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Charles Clifton Wykoff, PHD, MD for Medicare patients.

The highest averages for the top procedures that Dr. Charles Clifton Wykoff, PHD, MD treated as a retina specialist in Houston, TX were eye procedures, injections, photocoagulation and aspiration.

aspiration	24
diagnostic imaging	14
doctor visit	217
eye procedures	7296
injections	2332
photocoagulation	48
prophylaxis (preventive treatment)	23
ultrasound (sonogram)	14

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD.

**Gender**
Male	391
Female	491

**Ethnicity**
Black / African American	41
Asian / Pacific Islander	16
Non-Hispanic White	743
Native American / Alaskan Native	0
Hispanic	56
Other	5

**Age**
75 to 84	292
85 and over	177
Less than 65	50
65 to 74	362

Average of Total of Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Charles Clifton Wykoff, PHD, MD treated were hypertension, high cholesterol, ischemic heart disease and diabetes.

Hypertension	60
High Cholesterol	48
Stroke	4
Ischemic Heart Disease	31
Depression	13
Chronic Kidney Disease	24
Asthma	5
Osteoporosis	8
Heart Failure	16
Chronic Obstructive Pulmonary Disease	10
Diabetes	29
Atrial Fibrillation	10
Cancer	8
Dementia	9

Education & Training

Dr. Charles Clifton Wykoff, PHD, MD graduated from Harvard Medical School in 2005. He completed residency at Bascom Palmer Eye Institute. He has a state license in Texas.

Medical School: Harvard Medical School (2005)

Residency: Bascom Palmer Eye Institute (2009)

Licensed In: Texas

Affiliations & Hospitals

Dr. Charles Clifton Wykoff, PHD, MD is associated with these hospitals and organizations:

Baylor College of Medicine

Houston Methodist

Memorial Hermann

RETINA CONSULTANTS OF HOUSTON PLLC

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Charles Clifton Wykoff, PHD, MD appears to accept the following insurance providers: Aetna, Amerigroup Star Plus, Amerigroup Star, Medicare Advantage, Amerigroup, BlueCross BlueShield of Texas, Aetna Medicare, Memorial Hermann Advantage HMO, Memorial Hermann Solutions, WorkLink Worker's Comp, HMO Blue Texas, Amerivantage and Memorial Hermann Advantage PPO.

Insurance Accepted by Provider includes:

According to our sources, Dr. Charles Clifton Wykoff, PHD, MD accepts the following insurance providers:

Aetna

Amerigroup Star Plus

Amerigroup Star

Medicare Advantage

Amerigroup

BlueCross BlueShield of Texas

Aetna Medicare

Memorial Hermann Advantage HMO

Memorial Hermann Solutions

WorkLink Worker's Comp

HMO Blue Texas

Amerivantage

Memorial Hermann Advantage PPO

Show More

Ratings & Reviews

Dr. Charles Clifton Wykoff, PHD, MD does not have any reviews yet, be the first to leave a review of Dr. Charles Clifton Wykoff, PHD, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Charles Clifton Wykoff, PHD, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Regeneron Healthcare Solutions, Inc.	$252,060 EYLEA aflibercept injection $150,087	Eylea $95,141	EYLEA HD $5,920	EYLEA (aflibercept) Injection $866	$45
Regeneron Pharmaceuticals, Inc.	$193,795 Eylea $94,909	EYLEA (aflibercept) Injection $52,830	EYLEA aflibercept injection $36,266	EYLEA HD $46	$9,743
Allergan Inc.	$168,945 OZURDEX $165,060	BOTOX $744	RESTASIS $128	COMBIGAN $125	$2,889
Genentech USA, Inc.	$132,575 LUCENTIS $102,743	SUSVIMO $12,963	Non-Covered Product $5,572	VABYSMO $200	$11,097
Novartis Pharma AG	$119,708 BEOVU $46,602	BLZ_BEOVU_OPHTHALMOLOGY $29,014	BVU_BEOVU_OPHTHALMOLOGY $15,050	RTH258A_BEOVU_OPHTHALMOLOGY $11,580	LUCENTIS $9,343	Other $8,119
Other	$638,121 Non-Covered Product $75,322	LUCENTIS $55,081	BEOVU $36,217	ILUVIEN $26,507	YUTIQ $18,834	Other $426,159

**Types of Payments**
Consulting Fee	$968,076
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$381,457
Travel and Lodging	$109,679
Food and Beverage	$30,969
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$7,880
Other	$7,143

Research Payments

Dr. Charles Clifton Wykoff, PHD, MD has received 1262 research payments totaling $40,301,106.

Biography

Dr. Charles Wykoff is a physician who specializes in vitreoretinal diseases (retina and vitreous). Dr. Wykoff is especially interested in vitreous problems. His hospital/clinic affiliations include Houston Methodist, Memorial Hermann, and Baylor College of Medicine. He graduated from Harvard Medical School.

Select Year:

Dr. Charles Clifton Wykoff, PHD, MD

Office Locations

In The News (see more mentions in the news)

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2013 - 2021

Average Medicare Patient Data From 2013 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. Charles Clifton Wykoff, PHD, MD From 2013 - 2021

Education & Training

Affiliations & Hospitals

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

Retina Specialists in Nearby Locations

Other Providers in Houston, TX